BANK OF AMERICA CORP /DE/ - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 113 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,986,799
-20.2%
297,425
+0.3%
0.00%
Q2 2023$2,489,119
+57.2%
296,677
+86.1%
0.00%
Q1 2023$1,583,398
+160.0%
159,456
+82.3%
0.00%
Q4 2022$608,937
+7.2%
87,491
-17.9%
0.00%
Q3 2022$568,000
+7.4%
106,506
-19.7%
0.00%
Q2 2022$529,000
+30.3%
132,609
+45.3%
0.00%
Q1 2022$406,000
-69.7%
91,293
-72.7%
0.00%
Q4 2021$1,340,000
+63.8%
334,889
+259.9%
0.00%
Q3 2021$818,000
-26.5%
93,054
-5.3%
0.00%
Q2 2021$1,113,000
+172.8%
98,265
+186.3%
0.00%
Q1 2021$408,000
+700.0%
34,322
+359.5%
0.00%
Q4 2020$51,000
+4.1%
7,469
-35.9%
0.00%
Q2 2020$49,000
+88.5%
11,659
+10.1%
0.00%
Q1 2020$26,000
-62.9%
10,589
-11.9%
0.00%
Q4 2019$70,000
-5.4%
12,013
-13.8%
0.00%
Q3 2019$74,000
+8.8%
13,933
+24.5%
0.00%
Q2 2019$68,000
+25.9%
11,188
+87.7%
0.00%
Q1 2019$54,000
-47.1%
5,959
-51.1%
0.00%
Q4 2018$102,000
+45.7%
12,181
+139.4%
0.00%
Q3 2018$70,000
+191.7%
5,088
+64.2%
0.00%
Q2 2018$24,000
-31.4%
3,098
-32.9%
0.00%
Q1 2018$35,000
+45.8%
4,615
+31.9%
0.00%
Q4 2017$24,000
-55.6%
3,500
-53.3%
0.00%
Q3 2017$54,000
+28.6%
7,500
-16.7%
0.00%
Q2 2017$42,000
+5.0%
9,000
+12.5%
0.00%
Q1 2017$40,000
+25.0%
8,000
+33.3%
0.00%
Q4 2016$32,000
+3.2%
6,000
+50.0%
0.00%
Q3 2016$31,000
+72.2%
4,000
+22.9%
0.00%
Q2 2016$18,000
+125.0%
3,254
+62.7%
0.00%
Q1 2016$8,0002,0000.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders